As connected medical devices become more prevalent, cybersecurity regulations are evolving rapidly across global markets. Manufacturers must now navigate complex requirements from both the United States Food and Drug Administration (FDA) and the European Union (EU) to ensure compliance and protect patient safety. Fortunately, recent updates show promising signs of alignment between these regulatory bodies, making it easier for companies to adopt unified cybersecurity strategies.
Understanding the Regulatory Landscape
The FDA has introduced new cybersecurity requirements under Section 524B of the Omnibus Law, mandating Software Bill of Materials (SBOMs), coordinated vulnerability disclosure, and secure product development practices. Meanwhile, the EU is updating its Medical Device Regulation (MDR) and introducing the Cyber Resilience Act, which, although not directly applicable to medical devices, sets the tone for broader cybersecurity expectations.
Key Areas of Alignment
Both the FDA and EU regulators emphasize the importance of early threat modeling, SBOM transparency, and postmarket vulnerability management. They also encourage manufacturers to adopt global cybersecurity standards such as ISO/IEC 27001 and IEC 62443 to ensure consistent security practices across markets.
Benefits of Regulatory Harmonization
As the FDA and EU move toward harmonized cybersecurity expectations, manufacturers can benefit from streamlined product development, reduced compliance costs, and faster market access. Unified standards also help improve device security and patient trust across international markets.
How to Stay Ahead of Regulatory Changes
To stay ahead, manufacturers should monitor regulatory updates, engage in early cybersecurity planning, and collaborate with experts who understand both FDA and EU requirements. Proactive planning and secure design practices are essential for meeting current and future cybersecurity expectations.
Partner with Regulatory Compliance Associates®
Navigating the evolving cybersecurity landscape requires deep regulatory expertise and strategic planning. Regulatory Compliance Associates® (RCA) specializes in helping medical device companies align with global cybersecurity regulations, from SBOM development and threat modeling to FDA submissions and EU MDR compliance.
Contact RCA today to schedule a consultation and ensure your connected medical device is secure, compliant, and ready for global market access.
Regulatory Compliance Associates (RCA), a Nelson Labs company, along with Sterigenics and Nelson Labs, part of Sotera Health, offer an integrated suite of services tailored for wearable and implantable connected medical devices. From concept to commercialization, they help navigate complex regulatory landscapes, ensuring quality, safety, and speed to market.
Why Choose Us?
- Expert Guidance: Advisory services covering design, regulatory strategy, software development (including SaMD), cybersecurity, and risk management.
- Advanced Testing: Material compatibility, biocompatibility, battery performance, microbial testing, and more.
- Sterilization Excellence: Full-spectrum sterilization technologies including Gamma, EO, E-Beam, X-Ray, and Nitrogen Dioxide, with global GMP-certified facilities.
- Global Reach: Serving over 5,000 customers across 62 facilities in 13 countries.
Integrated Ecosystem for Connected Care
RCA, Sterigenics, and Nelson Labs support the entire connected device lifecycle, ensuring seamless integration with electronic health records and AI-driven care platforms.
Learn how RCA, Sterigenics, and Nelson Labs can accelerate your connected medical device project with unmatched expertise and global capabilities.